Welcome to Douglas Manufacturing
Douglas Manufacturing Limited is fully committed to the manufacture and distribution of affordable, high-quality healthcare products. At our state-of-the art plant and laboratories in Auckland, New Zealand, we offer you an end-to-end solution from development to delivery. Douglas Manufacturing is U.S. FDA approved, receiving the most recent approval for its manufacturing facilities in July 2015.
Click on each of the white buttons above to find out more.
We are proud of our specially designed containment area for the manufacture of our own range of products, which includes anticancer, immunosuppressants, steroid and retinoid softgel capsules.
A key part of our business includes Contract Manufacturing and/or Analytical Services for several multinationals as well as small generic companies.
Unlike many pharmaceutical manufacturers, we specialise in end-to-end services from product development to commercialisation.
From our state-of-the-art, GMP compliant manufacturing plants in New Zealand and Fiji, we can provide services from development of your product and analytical methods, manufacturing pilot scale/clinical batches, to commercial delivery. We have the capacity to undertake both containment and non contained manufacturing, packaging, warehousing and shipping.
Our plant and laboratories are licensed/approved by:
- TGA (Therapeutic Goods Administration of Australia)
- FDA (Food and Drug Administration of the USA)
- New Zealand Ministry of Health (Medsafe), and Ministry of Primary Industries (MPI) for the manufacture of both animal remedies and animal products.
The New Zealand Ministry of Health has in place a Mutual Recognition Agreement with the European Union that allows Douglas to export the pharmaceutical products it manufactures in New Zealand into the EU without the need for retest.
Our manufacturing capabilities are complemented by our state-of-the-art, internationally approved laboratories. We can offer full technical finished product or material analytical testing, stability, microbiology, product development and validation support.
We have dedicated containment suites for the manufacture of high-potency liquids and solid oral dosage forms (tablets, hard and soft gelatin capsules).
We have made a substantial investment to create a world class high-potency containment facility for manufacturing softgels. Douglas's intent is to combine the high-potency containment softgel manufacturing capability into its portfolio of other top-performing drug delivery systems.